tirzepatide vs semaglutide compounded vs. for Weight Loss difference between compounded semaglutide and

enrollment completedUSIsraelSelect immune-mediated diseasesExpanding 1assets TH103TH103 / VEGF / HSPG / Recombinant fusion protein / Retinal DiseasesNeovascular age-related macular degeneration (nAMD)Phase 1b/2OngoingDiabetic eye diseasePlannedPlannedRetinal vein occlusionPlannedPlanned 1assets 1assets Lomecel-Blaromestrocel 1assets LB-100LB-100 / Protein Phosphatase 2A (PP2A) / Small Molecule / OncologyOvarian Clear Cell CarcinomaPhase 2ActiveUnited StatesMetastatic Colon CancerPhase 1bActiveGlobalAdvanced Soft Tissue SarcomaPhase 1/2PausedEurope 1assets nomlabofuspCTI-1601 1assets SonelokimabM1095 / IL-17A and IL-17F (tri-specific Nanobody) / Nanobody (VHH) / Immunology (Dermatology and Rheumatology)Hidradenitis Suppurativa (HS)Phase 3OngoingGlobalAdolescent Hidradenitis Suppurativa (Teen HS)Phase 3OngoingGlobalPsoriatic Arthritis (PsA)Phase 3OngoingGlobal 1assets lorundrostatMLS-101 / Aldosterone synthase (CYP11B2) / Small molecule / Cardio-Renal-Metabolic SyndromeUncontrolled and treatment-resistant hypertensionPhase 3CompletedGlobalObstructive Sleep Apnea (OSA) and HypertensionPhase 2OngoingGlobalChronic Kidney Disease (CKD)Phase 2OngoingGlobal 1assets NBTXR3JNJ-1900 / Hensify / Tumor cell (Radioenhancer) / Functionalized hafnium oxide (HfO2) nanoparticles / OncologyLocally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC) - Platinum-ineligiblePhase 3OngoingGlobalRecurrent/Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)Phase 1/2OngoingGlobalSoft Tissue SarcomaApprovedMarketedEurope 1assets NKX019NKX019 / CD19 / Allogeneic CAR-NK Cell Therapy / Autoimmune DiseasesLupus NephritisSystemic SclerosisInflammatory Myopathy 1assets Tumor Treating FieldsTTFields / Optune Gio, Optune Lua, Optune Pax, Optune Mya / Mitotic spindle / Electric Field Therapy / OncologyGlioblastoma (GBM)ApprovedMarketedUnited StatesEuropeJapanGlioblastoma (GBM) - Earlier use (TRIDENT)Phase 3ActiveGlobalNon-Small Cell Lung Cancer (NSCLC)ApprovedMarketedUnited StatesJapanEurope 1assets PALI-2108PALI-2108 / PDE4 / Small Molecule Prodrug / GastroenterologyUlcerative Colitis (UC)Phase 2ActiveGlobalCrohn's Disease (CD)Phase 2ActiveGlobal 1assets DeucrictibantPHA121 1assets RezatapoptPC14586 1assets RilparencelREACT 1assets NimacimabCB1 / Monoclonal antibody / Metabolic DiseasesObesityPhase 2activeUnited States 1assets 1assets IvonescimabSMT112 / AK112 1assets Epinephrine nasal sprayARS-1 / neffy / Alpha and beta-adrenergic receptors / Small Molecule / Immunology & AllergyType I Allergic Reactions (including Anaphylaxis)ApprovedActiveUnited StatesEuropean UnionCanadaUrticaria (Acute Flares of Chronic Spontaneous Urticaria)Phase 2ActiveUnited States 1assets MolgramostimMolbreevi / GM-CSF receptor / Recombinant protein (rhGM-CSF) / Respiratory / Rare Lung DiseasesAutoimmune Pulmonary Alveolar Proteinosis (aPAP)SubmissionRegulatory SubmissionUSUKEU 1assets TERN-701TERN-701 / BCR::ABL1 / Small Molecule / OncologyChronic Myeloid Leukemia (CML)Phase 1/2ActiveGlobal 1assets pacibekitugTOUR006 / IL-6 / Monoclonal Antibody / Cardiovascular and Immune DiseasesAtherosclerotic Cardiovascular Disease (ASCVD)Phase 2ActiveGlobalThyroid Eye Disease (TED)Phase 2ActiveGlobalAbdominal Aortic Aneurysm (AAA)Phase 2PlannedGlobal 1assets 1assets idecabtagene vicleucelAbecma / BCMA / CAR-T Cell Therapy / OncologyRelapsed or refractory multiple myelomaMarketedApprovedUSEU 1assets verekitugUPB-101 / TSLP receptor (TSLPR) / Monoclonal antibody / Respiratory/Inflammatory DiseasesSevere AsthmaChronic rhinosinusitis with nasal polyps (CRSwNP)Chronic obstructive pulmonary disease (COPD) 1assets TelitaciceptRC18 / Taiai / BAFF/APRIL (BLyS/APRIL) / Recombinant Fusion Protein / Autoimmune DiseasesGeneralized Myasthenia Gravis (gMG)Phase 3Active / Approved in ChinaGlobalChinaSystemic Lupus Erythematosus (SLE)Phase 3Active / Approved in ChinaGlobalChinaRheumatoid Arthritis (RA)Phase 3Active / Approved in ChinaGlobalChina 1assets CadisegliatinTTP399 / Liver-selective glucokinase / Small molecule / EndocrinologyType 1 Diabetes (adjunctive to insulin)Phase 3OngoingUnited StatesType 2 DiabetesPhase 2PlannedUnited Arab Emirates 1assets AzenosertibZN-c3 / WEE1 / Small Molecule / OncologyCyclin E1-positive platinum-resistant ovarian cancer (PROC)Advanced solid tumors Adaptive Biotechnologies Corporation No pipeline0assets Adaptive Biotechnologies Corporation No pipeline No disclosed assets in this row.

| JGS KICKS

Obes Surg 33(4):10171025 Lautenbach A et al (2022) The potential of semaglutide once-weekly in patients without type 2 diabetes with weight regain or insufficient weight loss after bariatric surgerya retrospective analysis

In your initial consultation, our Registered Nurse will discuss your health background, go over your goals, and explain how weekly injections work

What India has seen so far may just be the tip of the iceberg

To reduce your monthly price, you can use the Habitual app to earn points and redeem them for rewards such as a discount on your next month